Total Payments
$14,369
2024 Payments
$1,380
Companies
57
Transactions
938
Medicare Patients
2,795
Medicare Billing
$195,373
Payment Breakdown by Category
Food & Beverage$14,317 (99.6%)
Education$52.67 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,317 | 933 | 99.6% |
| Education | $52.67 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,905 | 135 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,784 | 100 | $0 (2024) |
| Lilly USA, LLC | $1,336 | 99 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,148 | 77 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $980.67 | 57 | $0 (2024) |
| PFIZER INC. | $593.35 | 49 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $561.86 | 27 | $0 (2023) |
| ABBVIE INC. | $539.97 | 33 | $0 (2024) |
| Merck Sharp & Dohme LLC | $501.75 | 41 | $0 (2022) |
| Amgen Inc. | $477.41 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,380 | 70 | AstraZeneca Pharmaceuticals LP ($297.48) |
| 2023 | $1,667 | 96 | Lilly USA, LLC ($234.54) |
| 2022 | $2,060 | 115 | Novo Nordisk Inc ($355.69) |
| 2021 | $1,744 | 115 | Novo Nordisk Inc ($257.04) |
| 2020 | $1,854 | 119 | AstraZeneca Pharmaceuticals LP ($324.89) |
| 2019 | $1,857 | 139 | Novo Nordisk Inc ($305.06) |
| 2018 | $1,964 | 138 | GlaxoSmithKline, LLC. ($294.27) |
| 2017 | $1,843 | 146 | AstraZeneca Pharmaceuticals LP ($338.44) |
All Payment Transactions
938 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: PAIN | ||||||
| 12/10/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: VACCINES | ||||||
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Diabetes Care | ||||||
| 12/02/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Obesity | ||||||
| 11/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Respiratory | ||||||
| 10/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.35 | General |
| 09/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: VACCINES | ||||||
| 09/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: DIABETES | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Respiratory | ||||||
| 09/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Obesity | ||||||
| 09/10/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $75.14 | General |
| Category: Hematology | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Respiratory | ||||||
| 08/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.07 | General |
| 08/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Diabetes | ||||||
| 07/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 501 | 636 | $172,870 | $45,598 |
| 2022 | 16 | 835 | 1,151 | $234,064 | $63,150 |
| 2021 | 13 | 702 | 1,020 | $171,874 | $43,276 |
| 2020 | 12 | 757 | 961 | $174,355 | $43,349 |
Total Patients
2,795
Total Services
3,768
Medicare Billing
$195,373
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 219 | $83,418 | $16,848 | 20.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 45 | 46 | $39,153 | $12,706 | 32.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 68 | 68 | $26,135 | $8,838 | 33.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 28 | 28 | $5,875 | $1,870 | 31.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 44 | 45 | $3,339 | $1,328 | 39.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 20 | $5,393 | $1,189 | 22.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 58 | 59 | $3,235 | $1,089 | 33.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 33 | 33 | $3,069 | $914.81 | 29.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 45 | $1,883 | $379.92 | 20.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 19 | 26 | $780.00 | $247.52 | 31.7% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 12 | 12 | $228.00 | $73.32 | 32.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 13 | 13 | $208.00 | $66.04 | 31.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 20 | 22 | $154.00 | $48.40 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 160 | 273 | $104,821 | $20,281 | 19.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 59 | 59 | $46,859 | $16,302 | 34.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 92 | 92 | $36,052 | $11,959 | 33.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 48 | 49 | $9,594 | $3,332 | 34.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 16 | 16 | $8,048 | $2,644 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 37 | $10,101 | $2,427 | 24.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 63 | 63 | $3,321 | $1,797 | 54.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 55 | 58 | $3,057 | $1,651 | 54.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 20 | 20 | $4,420 | $609.81 | 13.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 22 | 66 | $2,838 | $549.59 | 19.4% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 74 | 78 | $1,482 | $480.90 | 32.4% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 74 | 78 | $1,248 | $399.84 | 32.0% |
About Dr. Daniel Chadwick, MD
Dr. Daniel Chadwick, MD is a Family Medicine healthcare provider based in Crowley, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508828245.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Chadwick, MD has received a total of $14,369 in payments from pharmaceutical and medical device companies, with $1,380 received in 2024. These payments were reported across 938 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($14,317).
As a Medicare-enrolled provider, Chadwick has provided services to 2,795 Medicare beneficiaries, totaling 3,768 services with total Medicare billing of $195,373. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Crowley, TX
- Active Since 04/06/2006
- Last Updated 05/30/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1508828245
Products in Payments
- FARXIGA (Drug) $1,398
- JARDIANCE (Drug) $969.42
- Ozempic (Drug) $574.43
- MOUNJARO (Drug) $485.95
- TRELEGY ELLIPTA (Drug) $472.82
- Vascepa (Drug) $403.97
- TRULICITY (Drug) $402.04
- OXTELLAR XR (Drug) $396.28
- CONTRAVE (Drug) $381.14
- JANUVIA (Drug) $323.38
- Saxenda (Drug) $316.57
- TRINTELLIX (Drug) $276.63
- Wegovy (Drug) $272.39
- Rybelsus (Drug) $253.46
- EMGALITY (Drug) $248.97
- VRAYLAR (Drug) $247.25
- Prolia (Biological) $223.04
- UBRELVY (Drug) $211.43
- Kerendia (Drug) $190.66
- SHINGRIX (Biological) $190.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Crowley
David Dunn, Md, MD
Family Medicine — Payments: $17,531
Family Medicine $17,531
Sheila Horsley, M.d, M.D
Family Medicine — Payments: $8,086
Family Medicine $8,086
Dr. Karrie Kilgore, M.d, M.D
Family Medicine — Payments: $5,201
Family Medicine $5,201
Dr. Paul Stringfellow, M.d, M.D
Family Medicine — Payments: $4,966
Family Medicine $4,966
Stephen Cannon, Md, MD
Family Medicine — Payments: $3,036
Family Medicine $3,036
Dr. Nancy Walker, M.d, M.D
Family Medicine — Payments: $2,762
Family Medicine $2,762